Canada vs Slovak Republic: Prevalence rate of obesity in adults
Canada
26.0%
in 2024
Slovak Republic
26.1%
in 2024
Canada rank
83rd
Slovak Republic rank
82nd
Prevalence rate of obesity in adults over time
- Canada
- Slovak Republic
How they compare
Slovak Republic currently reports 26.1% against 26.0% in Canada, a difference of 0.1%.
The two have swapped places 2 times across 45 shared years of data; in 1980 it was Slovak Republic ahead.
Canada ranks 83rd and Slovak Republic ranks 82nd of 199 countries.
Across the 5 decades both report, Canada averaged higher in 4 and Slovak Republic in 1.
Head to head by decade
| Decade | Canada | Slovak Republic | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 11.0% | 12.2% | 1.2% | Slovak Republic |
| 1990s | 16.8% | 13.8% | 3.0% | Canada |
| 2000s | 22.3% | 17.1% | 5.1% | Canada |
| 2010s | 25.0% | 21.8% | 3.2% | Canada |
| 2020s | 25.8% | 25.1% | 0.7% | Canada |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence rate of obesity in adults, Canada or Slovak Republic?
- Slovak Republic, at 26.1% against 26.0% in Canada as of 2024.
- What is the difference in prevalence rate of obesity in adults between Canada and Slovak Republic?
- 0.1%, with Slovak Republic ahead.
- How many years of comparable data are there for Canada and Slovak Republic?
- 45 years are reported by both, from 1980 to 2024.
- How do Canada and Slovak Republic rank globally for prevalence rate of obesity in adults?
- Canada ranks 83rd and Slovak Republic ranks 82nd of 199 countries.
- Where does this data come from?
- World Health Organization – Global Health Observatory (2026) – with minor processing by Our World in Data, published as Prevalence rate of obesity in adults. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated prevalence of obesity in adults, based on general population surveys and statistical modeling. Obesity is a risk factor for chronic complications, including cardiovascular disease, and premature death.